Fitterfly's findings reveal strong adoption of technology for lifestyle management amongst medical community, also correlating with reduction in medication intake Fitterfly, a leading health-tech company working in the field of digital therapeutics (DTx), has released a whitepaper on the advocacy of digital therapeutics among clinicians in
About 60% of people with uncontrolled diabetes are in the age group of 18-45 which poses a threat to the country’s economic growth as well Fitterfly, a leading health-tech company specializing in digital therapeutics (DTx), has released insightful data from the analysis of approximately 16,000
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
